Matherly L H, Fry D W, Goldman I D
Cancer Res. 1983 Jun;43(6):2694-9.
5-Formyltetrahydrofolate was found to reverse the binding of methotrexate to dihydrofolate reductase in the Ehrlich ascites tumor in vitro. When cells pretreated with methotrexate were resuspended in methotrexate-free buffer containing 5-formyltetrahydrofolate (or 5-methyltetrahydrofolate), net dissociation of the antifolate from the enzyme was observed. Methotrexate associated with the enzyme under these conditions was below the enzyme binding capacity. However, glucose or azide increased the fraction of dihydrofolate reductase associated with methotrexate and abolished the effect of tetrahydrofolates on this intracellular component. Addition of 5-fluoro-2'-deoxyuridine had no effect on this response to the reduced folate, thereby precluding a direct role for the thymidylate synthase-dependent generation of dihydrofolate in this dissociation of methotrexate from dihydrofolate reductase. Enzyme-bound methotrexate could also be reduced by exposure to 5-formyltetrahydrofolate prior to uptake and efflux of free methotrexate. When cells were incubated under conditions which favored formation of methotrexate polyglutamate derivatives, subsequent treatment with 5-formyltetrahydrofolate had no effect on the binding of the conjugated antifolate to dihydrofolate reductase. These findings support a role for dihydrofolate reductase as a locus for competitive binding interactions between reduced folates and methotrexate that may be a basis for the ability of 5-formyltetrahydrofolate to prevent the biochemical effects of this antifolate. These data suggest that the presence of methotrexate polyglutamate derivatives and cellular energy metabolism may be critical determinants of the responsiveness of methotrexate-treated cells to reduced folates and may play important roles in the selectivity of 5-formyltetrahydrofolate rescue.
在体外实验中发现,5-甲酰四氢叶酸可逆转甲氨蝶呤与艾氏腹水瘤中二氢叶酸还原酶的结合。当用甲氨蝶呤预处理过的细胞重悬于含有5-甲酰四氢叶酸(或5-甲基四氢叶酸)的无甲氨蝶呤缓冲液中时,可观察到抗叶酸药物从酶上的净解离。在这些条件下与酶结合的甲氨蝶呤低于酶的结合能力。然而,葡萄糖或叠氮化物增加了与甲氨蝶呤结合的二氢叶酸还原酶的比例,并消除了四氢叶酸对这种细胞内成分的影响。添加5-氟-2'-脱氧尿苷对这种对还原型叶酸的反应没有影响,从而排除了胸苷酸合酶依赖性生成二氢叶酸在甲氨蝶呤从二氢叶酸还原酶解离过程中的直接作用。在游离甲氨蝶呤摄取和流出之前,通过暴露于5-甲酰四氢叶酸也可使与酶结合的甲氨蝶呤减少。当细胞在有利于形成甲氨蝶呤多聚谷氨酸衍生物的条件下孵育时,随后用5-甲酰四氢叶酸处理对结合型抗叶酸药物与二氢叶酸还原酶的结合没有影响。这些发现支持二氢叶酸还原酶作为还原型叶酸与甲氨蝶呤之间竞争性结合相互作用位点的作用,这可能是5-甲酰四氢叶酸预防这种抗叶酸药物生化作用能力的基础。这些数据表明,甲氨蝶呤多聚谷氨酸衍生物的存在和细胞能量代谢可能是甲氨蝶呤处理细胞对还原型叶酸反应性的关键决定因素,并且可能在5-甲酰四氢叶酸解救的选择性中起重要作用。